NMR
Get informed when a big investor buys or sells
+ FollowJuly 29, 2026 - AI Summary
Overvalued by 138.4% based on the discounted cash flow analysis.
| Market cap | $29.08 Billion |
|---|---|
| Enterprise Value | $29.05 Trillion |
| Dividend Yield | $0.32 (3.27%) |
| Earnings per Share | $123.08 |
| Beta | 0.6 |
| Outstanding Shares | 2,917,278,000 |
| P/E Ratio | 0.32 |
|---|---|
| PEG | 0.81 |
| Price to Sales | 0.01 |
| Price to Book Ratio | 0.01 |
| Enterprise Value to Revenue | 5.84 |
| Enterprise Value to EBIT | 62.47 |
| Enterprise Value to Net Income | 69 |
| Total Debt to Enterprise | 1.21 |
| Debt to Equity | 9.18 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | - |
Holdings and activity of institutional investors.
| Ownership % | 0.90%▼ 1.97% |
|---|---|
| Total Invested | $233.31M▼ 65.06% |
| Investors Holding | 153▼ 121.00% |
No data